Gilead Announces $3,120 Price Tag for COVID-19 Drug Developed With $70 Million in Taxpayer Money

EcoWatch
By Common DreamsJun 30, 2020, 9:49 am437 pts
By Jake Johnson Consumer advocates reacted with disgust Monday to an announcement by Gilead Sciences that it will charge U.S. hospitals around $3,120 per privately insured patient for a treatment course of remdesivir, a drug which has proven modestly effective at speeding Covid-19 recovery times. Peter…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

New dataset sheds light on relationship of far-red sun-induced chlorophyll fluorescence to canopy-level photosynthesis 115

Molecular mechanism of CmoDREB2A and CmoNAC1 in pumpkin regulating the salt tolerance of grafted cucumber revealed 108

Tesla Superchargers, Stores, & Service Fleet Up Significantly In 1st Quarter 107

‘It’s Got to Be a Fight’: Author Adam Welz on Surviving Climate Breakdown and Saving Species of a ‘Tarnished Eden’ 102

Biden-Harris Administration Finalizes Suite of Standards to Reduce Pollution from Fossil Fuel-Fired Power Plants 100

Can Climate Change Accelerate Transmission of Malaria? Pioneering Research Sheds Light on Impacts of Temperature 92

How Much Energy Can Offshore Wind Farms in the US Produce? New Study Sheds Light 91

A Giant Plastics Chemical Recycling Plant Planned for Pennsylvania Died After Two Years. What Happened? 90

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.